23/10/2026
Can you predict what a drug combination will do just by looking at each drug on its own? 🧬
PhD researcher Freya Weth at the Gillies McIndoe Research Institute asked this question about glioblastoma. She tested repurposed drugs on patient-derived 3D models and measured the effects at the protein level.
Using Omics Playground, she found that a four-drug combination was effective in all eight patient-derived models. Its molecular effects were more than the sum of its parts: energy-producing pathways in the mitochondria (the TCA cycle, oxidative phosphorylation and the electron transport chain) were suppressed more strongly than the single drugs predicted. Not every patient responded the same way, though. Some models showed a distinct profile, including higher levels of resistance-associated proteins.
She did it all without building a manual R workflow, from handling missing values and patient-to-patient variation to zooming in on individual pathways and proteins.
We’re proud to support Freya’s research and can’t wait to see what she finds next!
Read the full story 👉 https://eu1.hubs.ly/H0zlmKZ0
See how a researcher at the Gillies McIndoe Research Institute used Omics Playground to uncover patient-specific proteomic responses in glioblastoma.